Literature DB >> 23554026

In vivo identification of sentinel lymph nodes using MRI and size-controlled and monodispersed magnetite nanoparticles.

Shuji Iida1, Kensuke Imai, Sachiko Matsuda, Osamu Itano, Mamoru Hatakeyama, Satoshi Sakamoto, Daisuke Kokuryo, Koji Okabayashi, Takashi Endo, Yoshiyuki Ishii, Hirotoshi Hasegawa, Ichio Aoki, Hiroshi Handa, Yuko Kitagawa.   

Abstract

PURPOSE: To develop a sentinel lymph node (SN) identification method using accurately synthesized magnetic nanoparticles (MNPs), as an enhanced specific SN tracer in combination with magnetic resonance imaging (MRI) in intact rodent and SN metastasis models.
MATERIALS AND METHODS: Three sizes of MNPs were originally synthesized. We developed an experimental rat SN model, with brachial lymph nodes (Br) as the SN and the axillary lymph node (Ax) as the second lymph node, and injection of MNPs via the front paw. SN detectability was evaluated in vivo using T1 -weighted MR images after injection of the synthesized MNPs, and the amount of iron in the Br and in the Ax was assessed using inductively coupled plasma optical emission spectrometry.
RESULTS: The highest ratios of the amount of iron in the Br versus the Ax were 3.1 and 3.3, using 20-nm MNPs after 2- and 24-hour injections. The appropriate dose and particle diameter for MRI detection was optimized, and the SN was optimally distinguished in the normal and metastatic rat models using MRI after a 0.4 mg/kg 20-nm MNP injection.
CONCLUSION: We developed and optimized a useful SN identification method using MRI in rodent models.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  MRI; detection; magnetic nanoparticles; sentinel lymph node

Mesh:

Substances:

Year:  2013        PMID: 23554026     DOI: 10.1002/jmri.24108

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  6 in total

1.  Pre-operative sentinel lymph node localization in breast cancer with superparamagnetic iron oxide MRI: the SentiMAG Multicentre Trial imaging subprotocol.

Authors:  Joost J Pouw; Maarten R Grootendorst; Roland Bezooijen; Caroline A H Klazen; Wieger I De Bruin; Joost M Klaase; Margaret A Hall-Craggs; Michael Douek; Bennie Ten Haken
Journal:  Br J Radiol       Date:  2015-10-22       Impact factor: 3.039

2.  Comparison of three magnetic nanoparticle tracers for sentinel lymph node biopsy in an in vivo porcine model.

Authors:  Joost J Pouw; Muneer Ahmed; Bauke Anninga; Kimberley Schuurman; Sarah E Pinder; Mieke Van Hemelrijck; Quentin A Pankhurst; Michael Douek; Bennie Ten Haken
Journal:  Int J Nanomedicine       Date:  2015-02-11

3.  Size-dependent lymphatic uptake of nanoscale-tailored particles as tumor mass increases.

Authors:  Pontus Kjellman; Sarah Fredriksson; Christian Kjellman; Sven-Erik Strand; René In 't Zandt
Journal:  Future Sci OA       Date:  2015-11-01

4.  Establishment of a model of sentinel lymph node metastasis using immunodeficient swine.

Authors:  Toshiaki Kurihara; Sachiko Matsuda; Yuki Nakamura; Shunichi Suzuki; Daiichiro Fuchimoto; Akira Onishi; Kohei Saeki; Takayuki Nakagawa; Reina Fujiwara; Masatoshi Kamata; Junko Kuramoto; Kaori Kameyama; Masaki Sekino; Moriaki Kusakabe; Tetsu Hayashida; Hiromitsu Jinno; Yuko Kitagawa
Journal:  Sci Rep       Date:  2019-05-28       Impact factor: 4.379

5.  Magnetic resonance sentinel lymph node imaging and magnetometer-guided intraoperative detection in prostate cancer using superparamagnetic iron oxide nanoparticles.

Authors:  Alexander Winter; Tobias Kowald; Tina Susanne Paulo; Philipp Goos; Svenja Engels; Holger Gerullis; Jonas Schiffmann; Ajay Chavan; Friedhelm Wawroschek
Journal:  Int J Nanomedicine       Date:  2018-10-23

6.  Diagnostic Accuracy of Magnetometer-Guided Sentinel Lymphadenectomy After Intraprostatic Injection of Superparamagnetic Iron Oxide Nanoparticles in Intermediate- and High-Risk Prostate Cancer Using the Magnetic Activity of Sentinel Nodes.

Authors:  Wiebke Geißen; Svenja Engels; Paula Aust; Jonas Schiffmann; Holger Gerullis; Friedhelm Wawroschek; Alexander Winter
Journal:  Front Pharmacol       Date:  2019-10-11       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.